Stay updated on Zolbetuximab Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.

Latest updates to the Zolbetuximab Combo in Gastric Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedExpanded the Location list to include numerous new sites across many countries and regions. Several previous location groups were removed.SummaryDifference3%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.2; updates from the previous v3.3.1 version.SummaryDifference0.0%

- Check38 days agoChange DetectedEditorial notes were updated: a new statement clarifies PubMed auto-fill and Revision: v3.3.1; the older PubMed wording and Revision: v3.2.0 were removed. These are editorial changes that do not affect substantive study data or eligibility criteria; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedThe study locations list includes a new site: Tainan, Taiwan, 704. The entry for Tainan City, Taiwan, 704 is replaced with Tainan, Taiwan, 704 in the locations section.SummaryDifference0.1%

- Check53 days agoChange DetectedThe study's update history now includes new date entries (2025-11-03, 2025-10-29, 2025-10) and removes older entries (2025-09-03, 2025-08-13, 2025-08).SummaryDifference0.1%

- Check60 days agoChange DetectedUpdated study locations: added Cali, Colombia (Cali, Valle del Cauca Department) and removed Santiago de Cali, Colombia (Santiago de Cali, Valle del Cauca Department).SummaryDifference0.2%

Stay in the know with updates to Zolbetuximab Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.